Horizon Flexible Income ETF (FLXN)

$25.76

Last Close (24-hour delay)

PASS

BUY Advisory
SELL Advisory (Profit)
SELL Advisory (Loss)

Profit
Loss
Pass (Skip investing)

Time period over

ALL
YEAR
MONTH
WEEK

Upturn Advisory Summary

10/24/2025: FLXN (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF

Historic Profit 0%

Avg. Invested days 0

Today’s Advisory PASS

Upturn Star Rating

Upturn Advisory Performance

1.0

ETF Returns Performance

1.0

Profits based on simulation

Last Close 10/24/2025

Key Highlights

Volume (30-day avg) -	Beta 1.53	52 Weeks Range -	Updated Date 01/16/2022
52 Weeks Range -	Updated Date 01/16/2022

About Flexion Therapeutics Inc

Exchange NASDAQ	Headquaters Burlington, MA, United States
IPO Launch date 2014-02-12	Co-Founder, Pres, CEO & Director Dr. Michael D. Clayman M.D.
Sector Healthcare	Industry Drug Manufacturers-Specialty & Generic	Full time employees 257	Website http://www.flexiontherapeutics.com
Full time employees 257	Website http://www.flexiontherapeutics.com

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. As of November 19, 2021, Flexion Therapeutics, Inc. operates as a subsidiary of Pacira BioSciences, Inc..

https://www.upturn.io

Disclosure Privacy Policy Terms of Use Sitemap Contact Us

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.